Probiotic delivers anticancer drug to the gut
Researchers at WashU Medicine engineered a yeast probiotic to deliver immunotherapy to the gut where it reduced gastrointestinal tumors in mice, offering a potentially novel strategy to target hard-to-reach gut cancers.
Researchers define new subtypes of common brain disorder
Researchers at WashU have used AI tools to describe three sub-types of Chiari type-1, which will help guide clinicians to make the most effective treatment decisions for their patients.
WashU faculty, alumni lead effort to repair harms caused by systemic racism in St. Louis
Several WashU faculty members contributed to the St. Louis Reparations Commission report, which outlined recommendations for city officials to repair the harm caused by racial injustice.
Vaccine shows promise against aggressive breast cancer
A small clinical trial conducted at WashU Medicine shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors.
WashU Medicine, BJC Health System launch Center for Health AI
Washington University School of Medicine in St. Louis and BJC Health System have launched the joint Center for Health AI. The center will focus on making care more personalized and effective for patients and more efficient and manageable for physicians, nurses and all those striving to ensure patients receive the best care.
Yoo receives grant from Hereditary Disease Foundation
Andrew Yoo, a professor of developmental biology at WashU Medicine, has received the 2024 Transformative Research Award, a two-year $1 million grant from the Hereditary Disease Foundation.
Researchers make glioblastoma cells visible to attacking immune cells
Researchers at WashU Medicine have identified a possible way to make brain cancer cells vulnerable to different types of immunotherapy, in hopes of finding new treatments for one of the most deadly cancers.
Researchers solve medical mystery of neurological symptoms in kids
Researchers at WashU Medicine collaborated with an international team of doctors and scientists to identify the cause of a rare genetic disorder involving intellectual disability and brain malformations.
Jin receives NIH grant to study congenital hydrocephalus
Sheng Chih (Peter) Jin, an assistant professor of genetics at WashU Medicine, has received a $3.2 million grant from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health (NIH) to study the genetic and molecular underpinnings of congenital hydrocephalus.
Four from radiology named Distinguished Investigators
Four WashU faculty members were named Distinguished Investigators by the Academy for Radiology & Biomedical Imaging Research.
View More Stories